Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 9 years
- Director since
- 2023
9 years of board service in total across 3 boards, counting each seat separately. Longest: TScan Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Xencor Inc. June 16, 202696.4%
-
Xencor Inc. June 12, 202597.6%
-
ALX Oncology Holdings Inc. June 11, 202595.6%
-
Xencor Inc. June 13, 202498.2%
-
TScan Therapeutics Inc. June 12, 202499.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 16, 2026 | Xencor Inc. | Grant or award | +10,302 | — | — |
| Jun 12, 2025 | Xencor Inc. | Grant or award | +13,686 | — | — |
| Sep 23, 2024 | TScan Therapeutics Inc. | Open-market purchase | +5,000 | $5.29 | $26,450 |
| Aug 26, 2024 | TScan Therapeutics Inc. | Open-market purchase | +5,000 | $5.53 | $27,650 |
| Aug 23, 2024 | TScan Therapeutics Inc. | Open-market purchase | +5,000 | $5.69 | $28,450 |
| Jun 13, 2024 | Xencor Inc. | Grant or award | +5,986 | — | — |
| Dec 14, 2023 | TScan Therapeutics Inc. | Open-market purchase | +5,000 | $5.08 | $25,400 |
Questions about Barbara Klencke
What boards is Barbara Klencke on?
Barbara Klencke sits on the boards of ALX Oncology Holdings Inc., TScan Therapeutics Inc. and Xencor Inc.
How long has Barbara Klencke served on boards?
Our records show at least 9 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.